Planta Med 2016; 82(S 01): S1-S381
DOI: 10.1055/s-0036-1596911
Georg Thieme Verlag KG Stuttgart · New York

Synergistic hepatoprotective effect of Combretum dolichopetalum root and sylimarin in rats

PF Uzor
1  Department of Pharmaceutical and Medicinal Chemistry, University of Nigeria, Nsukka, 410001, Nigeria
CG Ezeah
1  Department of Pharmaceutical and Medicinal Chemistry, University of Nigeria, Nsukka, 410001, Nigeria
› Author Affiliations
Further Information

Publication History

Publication Date:
14 December 2016 (online)


Liver diseases are constantly posing global challenge as the liver is a vital organ responsible for the detoxification of drugs and xenobiotics in the body. Herbal drugs are useful for the treatment of hepatotoxicity [1]. Combretum dolichopetalum root extract (ME) has been demonstrated to exhibit hepatoprotective effect [2]. Also sylimarin (SLN), a standardized extract of Silybum marianum, is used as a standard drug for hepatic diseases [3]. Despite the availability of several herbal remedies for liver toxicity, the therapy for liver disease remains unsatisfactory. Combination of herbal interventions is one effective means for the treatment of liver diseases [4]. The aim of the present study was to evaluate the hepatoprotective effect of C. dolichopetalum combined with SLN on CCl4 – induced hepatotoxic rats. Six groups of rats (n = 5) received different treatments for 2 weeks thus: group 1 received CCl4 only (2 ml/kg, i.p) (control group), group 2 received vehicle only (0.5 ml/kg, p.o), group 3 received CCl4 (2 ml/kg, i.p) + ME (100 mg/kg, p.o), group 4 received CCl4 (2 ml/kg, i.p) + SLN (25 mg/kg, p.o), group 5 received CCl4 (2 ml/kg, i.p) + ME (50 mg/kg, p.o) + SLN (12.5 mg/kg, p.o) and group 6 received CCl4 (2 ml/kg, i.p) + ME (200 mg/kg, p.o)+ SLN (50 mg/kg, p.o). At the end of 2 weeks, the rats were sacrificed and blood samples were collected for biochemical analyses including aspartate aminotransferase (AST), superoxide dismutase (SOD), malonyldialdehyde (MDA) and heamoglobin. Liver section was taken for histopathological examination. Results showed that the combined ME and SLN (groups 5 and 6) improved (p < 0.001) the biochemical parameters better than any of the agents used alone. Histopathological results corroborated the biochemical results. It was concluded that C. dolichopetalum root acts in synergy with sylimarin to protect the liver cells from CCl4 - induced liver damage.

Keywords: Combretum dolichopetalum, hepatoprotective, synergy, sylimarin.


[1] Manoj S, Mohanty PK, Jaliwala YA. Hepatoprotective activity of fruits of Prunus domestica. Int J Pharma Bio Sci 2011; 2: 439 – 453

[2] Udem SC, Madubunyi I, Okoye JOA, Anika SM. Anti-hepatotoxic effects of the ethanolic extracts of Combretum dolichopetalum root bark and Morinda lucida leaf. Fitoterapia 1997; 68: 21 – 24

[3] Saller R, Meier R, Brignoli R. The use of silymarin in the treatment of liver diseases. Drugs 2001; 61: 2035 – 2063

[4] Singh G, Goyal R, Sharma PL. Pharmacological potential of silymarin in combination with hepatoprotective plants against experimental hepatotoxicity in rats. Asian J Pharm Clin Res 2012; 5 (Suppl 1): 128 – 133